FDA Approval of Nusinersen for Spinal Muscular Atrophy Makes 2016 the Year of Splice Modulating Oligonucleotides

标题
FDA Approval of Nusinersen for Spinal Muscular Atrophy Makes 2016 the Year of Splice Modulating Oligonucleotides
作者
关键词
-
出版物
Nucleic Acid Therapeutics
Volume 27, Issue 2, Pages 67-69
出版商
Mary Ann Liebert Inc
发表日期
2017-02-22
DOI
10.1089/nat.2017.0665

向作者/读者发起求助以获取更多资源

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now